Dawn Mason
Psychiatric/Mental Health · Spokane, WANPI 1033685169
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,475 of the $25,129 with a category attached, or 69.5%. AbbVie accounts for 79.7% of it on its own, with 33 other manufacturers making up the rest. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $74.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$20K
- Neurocrine Biosciences, Inc.$597
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$544
- Teva Pharmaceuticals USA, Inc.$539
- Johnson & Johnson$484
- Biogen$471
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$17,47570%
- Travel & lodging$9664%
- Food & beverage$6,64126%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 109 | $20,018 |
| Neurocrine Biosciences, Inc. | 23 | $597 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $544 |
| Teva Pharmaceuticals USA, Inc. | 44 | $539 |
| Johnson & Johnson | 9 | $484 |
| Biogen | 37 | $471 |
| Axsome Therapeutics, Inc. | 7 | $425 |
| Novartis | 15 | $217 |
| Amgen | 10 | $186 |
| Biohaven Pharmaceuticals, Inc. | 12 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $152 |
| Lilly USA, LLC | 6 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Lundbeck LLC | 7 | $120 |
| Alkermes, Inc. | 1 | $116 |
| Merz Pharmaceuticals, LLC | 3 | $101 |
| Novo Nordisk | 1 | $85 |
| Amneal Pharmaceuticals LLC | 5 | $85 |
| Upsher-smith Laboratories LLC | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Idorsia Pharmaceuticals US Inc | 2 | $48 |
| Acadia Pharmaceuticals Inc | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Banner Life Sciences, LLC | 2 | $39 |
| Avanir Pharmaceuticals, Inc. | 2 | $36 |
| Livanova USA, Inc. | 1 | $31 |
| CSL Behring | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $29 |
| Merz North America, Inc. | 1 | $27 |
| Acorda Therapeutics, Inc | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| EMD Serono, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,129 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lithium Carbonate ErLithium Carbonate | 15 | $156 |
| Trazodone Hcl | 14 | $125 |
| Buspirone Hcl | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Spokane
- Favor OsakweSpokane$10K
- Colleen MooreSpokane$8K
- Nicholas GoodwinSpokane$5K
- Margaret KyakuwaSpokane$5K
- Kiira TietjenSpokane$5K
- Angela HamelSpokane$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Jennifer WilsonYakima$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.